Catalent Completes Chinese Softgel Acquisition

- Last updated on GMT

Related tags: China, Management

Catalent Completes Chinese Softgel Acquisition
Catalent has completed the purchase of a Chinese softgel firm following regulatory approval.

The acquisition of Zhejiang Jiang Yuan Tang Biotechnology was agreed back in March with Catalent Pharma Solutions telling in-Pharmatechnologist.com​ the deal would build upon its existing softgel network in Asia Pacific and complement existing facilities in Japan and Australia.

Now with regulatory requirements met, the firm holds the majority share of Zhejiang Jiang Yuan Tang, based in Haining, and employer of 120.

Speaking in March, Catalent spokesperson Chris Halling told us: “Growing our capabilities in China and Asia more broadly is a key goal for Catalent and has commanded substantial focus from Catalent senior management over the last year and will continue to in the future.”

In April Catalent named Weiyan “Jackson” Zhu​ as Country General Manager for China.

The firm is also targeting the Asian market with a 31,000 sq ft clinical trials facility under construction in Shanghai.

Related news

Show more

Related products

show more

Fill Release at the Right Time in the Right Place

Fill Release at the Right Time in the Right Place

Gelita AG | 19-Sep-2018 | Technical / White Paper

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Related suppliers

Follow us

Products

View more